GB1341222A - Oxadiazole derivatives - Google Patents

Oxadiazole derivatives

Info

Publication number
GB1341222A
GB1341222A GB138771A GB138771A GB1341222A GB 1341222 A GB1341222 A GB 1341222A GB 138771 A GB138771 A GB 138771A GB 138771 A GB138771 A GB 138771A GB 1341222 A GB1341222 A GB 1341222A
Authority
GB
United Kingdom
Prior art keywords
benzamidoxime
formula
oxadiazole derivatives
compounds
ethoxycarbonyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB138771A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takeda Pharmaceutical Co Ltd
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Publication of GB1341222A publication Critical patent/GB1341222A/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D271/00Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
    • C07D271/02Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
    • C07D271/061,2,4-Oxadiazoles; Hydrogenated 1,2,4-oxadiazoles

Abstract

1341222 Oxadiazole derivatives TAKEDA YAKUHIN KOGYO KK 12 Jan 1971 [14 Jan 1970 17 April 1970] 1387/71 Heading C2C Novel oxadiazole derivatives of the formula wherein X is a free or esterified carboxy group or an unsubstituted or substituted carbamoyl group, R<SP>1</SP> and R<SP>2</SP> each are H, alkenyl, alkynyl, cycloalkyl, alkyl or aryl and R<SP>3</SP> is an optionally substituted hydrocarbon or heterocyclic group, and pharmaceutically acceptable salts thereof, are prepared by reacting compounds of the formula with carboxylic acids of the formula R<SP>3</SP>COOH or acid halides, acid anhydrides or esters thereof. 4 - (1 - Ethoxycarbonyl - 1 - methylethoxy) benzamidoxime, 4 - (1 - ethoxycarbonylethoxy) benzamidoxime, 4 - (1 - ethoxycarbonylpentyl) benzamidoxime, 4 - (α - ethoxycarbonylbenzyloxy) benzamidoxime and 4 - (1 - ethoxycarbonyl-1- cyclohexylmethoxy) benzamidoxime are obtained by hydroxylamine hydrochloride with the corresponding benzonitriles. Pharmaceutical compositions, suitable for oral or parenteral administration, contain the above novel compounds or acceptable salts thereof, together with pharmaceutically acceptable carriers, diluents or adjuvants. The compounds have hypocholesterolemic activity.
GB138771A 1970-04-17 1971-01-12 Oxadiazole derivatives Expired GB1341222A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP3334070 1970-04-17

Publications (1)

Publication Number Publication Date
GB1341222A true GB1341222A (en) 1973-12-19

Family

ID=12383821

Family Applications (1)

Application Number Title Priority Date Filing Date
GB138771A Expired GB1341222A (en) 1970-04-17 1971-01-12 Oxadiazole derivatives

Country Status (1)

Country Link
GB (1) GB1341222A (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5356916A (en) * 1991-03-22 1994-10-18 Wakamoto Pharmaceutical Co., Ltd. 1,2,4-oxadiazole derivatives having monoamine oxidase B enzyme-inhibitory activity
JP2005520858A (en) * 2002-03-20 2005-07-14 メタボレックス, インコーポレイテッド Substituted phenylacetic acid
JP2006516250A (en) * 2002-12-18 2006-06-29 サイトビア インコーポレイティッド 3,5-disubstituted- [1,2,4] -oxadiazoles and their derivatives and their use as caspase activators and apoptosis inducers

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5356916A (en) * 1991-03-22 1994-10-18 Wakamoto Pharmaceutical Co., Ltd. 1,2,4-oxadiazole derivatives having monoamine oxidase B enzyme-inhibitory activity
JP2005520858A (en) * 2002-03-20 2005-07-14 メタボレックス, インコーポレイテッド Substituted phenylacetic acid
JP2006516250A (en) * 2002-12-18 2006-06-29 サイトビア インコーポレイティッド 3,5-disubstituted- [1,2,4] -oxadiazoles and their derivatives and their use as caspase activators and apoptosis inducers

Similar Documents

Publication Publication Date Title
GB1495676A (en) Cephalosporins having an alpha-acylamino-acetic acid side chain
GB1447599A (en) Derivatives of alpha-methyldopa
GB1459065A (en) Therapeutic thiophene derivatives
GB1505885A (en) Substituted cephalosporins
GB1277239A (en) Cycloalkane-carboxylic acid derivatives
GB1341222A (en) Oxadiazole derivatives
GB1442828A (en) Esters of erythromycin oxime
GB1348737A (en) Cephalosporin derivatives
GB1415601A (en) Dihydrobetulinic acid derivatives
GB1398800A (en) Trisubstituted imidazoles
GB1529403A (en) Isoxazole derivative
GB1389827A (en) Tetrazolyl benzopyrans
GB1240224A (en) Improvements in or relating to hydroxylamine derivatives
GB1360860A (en) Cepham compounds process for their manufacture and compositions containing them
GB1358008A (en) Cephalosporin derivatives
GB1293702A (en) 4,5-diphenyloxazole derivatives
GB1411700A (en) Penicillins and production thereof
GB1451039A (en) Aryl carboxylic acids as hypolipemic agents
GB1316894A (en) Benzimidazole derivatives
GB1473971A (en) 3-hydroxy-5,6-benzomorphinan derivatives
GB1299201A (en) Medicaments derived from thiazolidine carboxylic acid
GB1203538A (en) Cubane derivatives
GB1441872A (en) Nitrobenzophenones
GB1173212A (en) Hydantoins and processes for the preparation thereof
GB1318479A (en) N-bicycloamino-alkanoyl-anilines

Legal Events

Date Code Title Description
PS Patent sealed
PCNP Patent ceased through non-payment of renewal fee